Executive leadership from Rainbow Coral Corp. (OTCBB: RBCC), a
fast-rising biotechnology company, will scout for new innovations and
potential partnerships this month at the sixth annual Biotech Showcase
in San Francisco.
Held January 13-15, the Biotech Showcase investor and partnering
conference is an established innovation forum for life science
investors. Executive-level delegates representing top public and private
investment firms come with the single aim to partner with emerging
biotechnology and life science companies.
It’s an ideal place for RBCC executives to meet and hear from
cutting-edge researchers and developers who could potentially help the
company achieve its ambitious goals in the booming global drug delivery
and personalized medicine markets.
"There’s no more important industry showcase in the U.S.," said RBCC CEO
Kimberly Palmer. "It’s the largest gathering of leading-edge,
growth-oriented biotech innovation in the country, and we’re
tremendously excited to make new contacts and, potentially, new
partnerships at the conference that could help make 2014 our best year
yet."
By acquiring or partnering with up-and-coming biotech innovators, RBCC
plans to be well-positioned to capitalize on the big growth in store for
the industry. The company invests in new technology developed to compete
in the biotechnology sector alongside Amgen (NASDAQ: AMGN), Dendreon
Corporation (NASDAQ: DNDN), Smith & Nephew (NYSE: SNN) and
Pharmaceutical Product Development (NASDAQ: PPDI).
For more information on RBCC’s other biotech initiatives, please visit www.rainbowbiosciences.com.
About Rainbow Biosciences
Rainbow Biosciences, LLC, is a wholly owned subsidiary of Rainbow Coral
Corp. (OTCBB: RBCC). The Company continually seeks out new partnerships
with biotechnology developers to deliver profitable new medical
technologies and innovations. For more information on our
growth-oriented business initiatives, please visit www.RainbowBioSciences.com.
Notice Regarding Forward-Looking Statements
Safe Harbor Statement under the Private Securities Litigation Reform Act
of 1995: This news release contains forward-looking information within
the meaning of Section 27A of the Securities Act of 1933, as amended,
and Section 21E of the Securities Exchange Act of 1934, as amended,
including statements that include the words "believes," "expects,"
"anticipate" or similar expressions. Such forward-looking statements
involve known and unknown risks, uncertainties and other factors that
may cause the actual results, performance or achievements of the Company
to differ materially from those expressed or implied by such
forward-looking statements. In addition, description of anyone's past
success, either financial or strategic, is no guarantee of future
success. This news release speaks as of the date first set forth above
and the Company assumes no responsibility to update the information
included herein for events occurring after the date hereof.
Copyright Business Wire 2014